KRAS and neoplasm: Conversely, NSD2 suppresses KRAS-driven pancreatic tumorigenesis by inducing the H3K36me2-dependent expression of IκBα, an inhibitor of NF-κB signaling, suggesting a putative tumor suppressive role [119].